CN108186483A - 一种天然抗衰老护肤组合物及其应用 - Google Patents
一种天然抗衰老护肤组合物及其应用 Download PDFInfo
- Publication number
- CN108186483A CN108186483A CN201810282709.3A CN201810282709A CN108186483A CN 108186483 A CN108186483 A CN 108186483A CN 201810282709 A CN201810282709 A CN 201810282709A CN 108186483 A CN108186483 A CN 108186483A
- Authority
- CN
- China
- Prior art keywords
- extract
- skin care
- sodium
- care compositions
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 230000032683 aging Effects 0.000 title claims abstract description 14
- 235000003325 Ilex Nutrition 0.000 claims abstract description 20
- 241000209035 Ilex Species 0.000 claims abstract description 20
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 20
- 244000078534 Vaccinium myrtillus Species 0.000 claims abstract description 20
- 235000013175 Crataegus laevigata Nutrition 0.000 claims abstract description 16
- 235000021028 berry Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 66
- 235000011187 glycerol Nutrition 0.000 claims description 33
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 32
- 239000012071 phase Substances 0.000 claims description 32
- 235000013399 edible fruits Nutrition 0.000 claims description 30
- 239000003755 preservative agent Substances 0.000 claims description 23
- 230000002335 preservative effect Effects 0.000 claims description 23
- -1 oligofructose Chemical compound 0.000 claims description 19
- 229910052708 sodium Inorganic materials 0.000 claims description 19
- 239000011734 sodium Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 17
- 235000008708 Morus alba Nutrition 0.000 claims description 17
- 241000241413 Propolis Species 0.000 claims description 17
- 235000013871 bee wax Nutrition 0.000 claims description 17
- 239000012166 beeswax Substances 0.000 claims description 17
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 17
- 229920000193 polymethacrylate Polymers 0.000 claims description 17
- 229940069949 propolis Drugs 0.000 claims description 17
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 16
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 16
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 16
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 16
- 241000218231 Moraceae Species 0.000 claims description 16
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 16
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 16
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 16
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 16
- 229920001577 copolymer Polymers 0.000 claims description 16
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 16
- 229960003966 nicotinamide Drugs 0.000 claims description 16
- 235000005152 nicotinamide Nutrition 0.000 claims description 16
- 239000011570 nicotinamide Substances 0.000 claims description 16
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 16
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 16
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 16
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 16
- 229920000053 polysorbate 80 Polymers 0.000 claims description 16
- 229940047670 sodium acrylate Drugs 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 16
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 16
- 239000004475 Arginine Substances 0.000 claims description 15
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 15
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 15
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 15
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 15
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 15
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 15
- 229940042585 tocopherol acetate Drugs 0.000 claims description 15
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 14
- 238000004945 emulsification Methods 0.000 claims description 14
- 229920000289 Polyquaternium Polymers 0.000 claims description 11
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 11
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 11
- OBRSPVMKYADWNI-SSZFMOIBSA-N C(CCCCCCC\C=C/CCCC)(=O)OC(CCCCCCCCCCC)CCCCCCCC Chemical compound C(CCCCCCC\C=C/CCCC)(=O)OC(CCCCCCCCCCC)CCCCCCCC OBRSPVMKYADWNI-SSZFMOIBSA-N 0.000 claims description 10
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 10
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 6
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 5
- 229940100573 methylpropanediol Drugs 0.000 claims description 5
- 229960001679 octinoxate Drugs 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims 2
- 235000003115 Diospyros discolor Nutrition 0.000 claims 1
- 240000000902 Diospyros discolor Species 0.000 claims 1
- 235000019109 Patrinia villosa Nutrition 0.000 claims 1
- 244000148137 Patrinia villosa Species 0.000 claims 1
- 241000220324 Pyrus Species 0.000 claims 1
- JSXROLUNEDJZJE-UHFFFAOYSA-N acetic acid;phenol Chemical class CC(O)=O.OC1=CC=CC=C1 JSXROLUNEDJZJE-UHFFFAOYSA-N 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 238000005260 corrosion Methods 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- 230000005094 fruit set Effects 0.000 claims 1
- 235000020717 hawthorn extract Nutrition 0.000 claims 1
- 235000021017 pears Nutrition 0.000 claims 1
- 229940100460 peg-100 stearate Drugs 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 abstract description 5
- 108010035532 Collagen Proteins 0.000 abstract description 5
- 229920001436 collagen Polymers 0.000 abstract description 5
- 230000006872 improvement Effects 0.000 abstract description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 150000002148 esters Chemical class 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 230000003712 anti-aging effect Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 244000270834 Myristica fragrans Species 0.000 description 6
- 235000009421 Myristica fragrans Nutrition 0.000 description 6
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 6
- 229940081733 cetearyl alcohol Drugs 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- 239000001702 nutmeg Substances 0.000 description 6
- 229960004063 propylene glycol Drugs 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940057874 phenyl trimethicone Drugs 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 3
- 206010040954 Skin wrinkling Diseases 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- 244000012254 Canarium album Species 0.000 description 2
- 235000009103 Canarium album Nutrition 0.000 description 2
- 241000251730 Chondrichthyes Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 235000011720 Vaccinium uliginosum Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000003138 coordinated effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical group C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000029951 Laryngeal disease Diseases 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000128206 Pyracantha coccinea Species 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- 241000251778 Squalus acanthias Species 0.000 description 1
- 240000008488 Thlaspi arvense Species 0.000 description 1
- 235000008214 Thlaspi arvense Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 235000012511 Vaccinium Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- OAQWWRSICWQQSE-UHFFFAOYSA-N octan-2-yl 16-methylheptadecanoate Chemical compound CCCCCCC(C)OC(=O)CCCCCCCCCCCCCCC(C)C OAQWWRSICWQQSE-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种天然抗衰老护肤组合物，所述的护肤组合物含有如下所述的原料：单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物；所述的单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物的质量之比为(1‑10)：(1‑10)：(1‑10)：(1‑10)。本发明护肤组合物能够有效提升皮肤含水量、促进胶原蛋白生成、改善肤色暗沉，有效抵御皮肤轻衰老。
Description
技术领域
本发明涉及化妆品领域，具体涉及一种天然抗衰老护肤组合物及其应用。
背景技术
由于生活所处的环境中，空气的干燥污浊、紫外线的干扰、工作压力、生活节奏等因素的影响，人们常常会出现皮肤过早黯淡、粗糙、发黄、长皱纹，甚至出现色斑、黄褐斑等轻衰老症状。而拥有光亮白皙的皮肤是每个爱美人士所期望的。因此，能够抵御上述皮肤轻衰老的化妆品将具有良好的市场前景。
发明内容
本发明要解决的技术问题是提供一种天然抗衰老护肤组合物。本发明护肤组合物能够有效提升皮肤含水量、促进胶原蛋白生成、改善肤色暗沉，有效抵御皮肤轻衰老。
本发明具体技术方案如下：
一种天然抗衰老护肤组合物，含有如下所述的原料：单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物；所述的单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)。
在其中一些实施例中，所述的护肤组合物还含有如下所述的原料：青果提取物、败酱草提取物、桑葚提取物、火棘果提取物；所述的青果提取物、败酱草提取物、桑葚提取物、火棘果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)。
在其中一些实施例中，所述的单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物、青果提取物、败酱草提取物、桑葚提取物、火棘果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)。
本发明还提供了所述的护肤组合物在制备化妆品中的应用，其中，所述护肤组合物的用量为最终产品用量的0.01-10％。
本发明还提供一种精华液，含有以下质量百分比的各组分：上述护肤组合物0.01-10％、甘油1-10％、丁二醇1-5％、羟乙基纤维素钠0.1-0.3％、低聚果糖0.1-0.5％、透明质酸钠0.01-0.05％、EDTA二钠0.01-0.05％、甲基丙二醇1-3％、甘草酸二钾0.05-0.15％、烟酰胺1-5％、甘油聚甲基丙烯酸酯0.1-0.5％、甲氧基肉桂酸乙基己酯0.1-0.5％、PEG-100硬脂酸酯0.1-0.5％、聚山梨醇酯-800.5-1％、山梨坦硬脂酸酯0.1-0.3％、角鲨烷1-10％、辛基十二醇肉豆蔻酸酯1-5％、辛酸/癸酸甘油三酯1-5％、异十六烷1-5％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.1-0.5％、鲸蜡硬脂醇0.5-1.5％、牛油果树果脂0.1-1％、苯基三甲基硅氧烷0.5-2.5％、蜂蜡0.1-1％、生育酚乙酸酯0.1-1％、防腐剂0.3-0.6％、精氨酸0.1-0.3％、蜂胶提取物0.1-1％、水余量。
在其中一些实施例中，所述防腐剂为聚季铵盐-15和1,2-己二醇的混合。
在其中一些实施例中，所述聚季铵盐-15和1,2-己二醇的质量之比为1:3。本发明将聚季铵盐-15和1,2-己二醇通过特定配比组合，能显著增加精华液的防腐杀菌效果，且温和无刺激。较单独使用1,2-己二醇效果更佳。
在其中一些实施例中，所述精华液的制备方法包括如下步骤：
1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散3-5分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质3-5分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散1-2分钟，搅拌均匀；降温至室温，出料。
与现有技术相比，本发明具有以下有益效果：
本发明轻衰老的护肤组合物能够有效提升皮肤含水量、促进胶原蛋白生成、改善肤色暗沉，有效抵御皮肤轻衰老。
本发明精华液复配了甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯五种乳化剂，在获得了良好的产品稳定性的基础上，获得了优良的产品使用感。复配了甲基丙二醇和辛基十二醇肉豆蔻酸酯，有利于产品中的功效成分渗透进入肌肤角质层；复配了蜂胶提取物，有利于去除老废角质，促进角质层更新；复配了蜂蜡、烟酰胺、低聚果糖、牛油果树果脂，为肌肤提供充足的营养物质，促进肌肤的新陈代谢，本发明所述的精华液的各种原料各有特色，相互促进，实现了协同的抵御肌肤轻衰老的作用。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚，下面将对本发明实施方式作进一步地详细描述，但本发明的实施方式不限于此，对于未特别注明的工艺参数或条件，可参照常规技术进行。
本发明所述的护肤组合物中所涉及的各成分简介如下：
单子山楂叶提取物：蔷薇科苹果亚科山楂属植物，主要分布在北温带大约北纬30°～50°的东亚、欧洲、北美等地。叶中富含大量的多元酚类成分，其中总黄酮量约为1.5％。多元酚类成分具有清除自由基，抗氧化作用，其中槲皮素、绿原酸、表儿茶素、金丝桃苷和芦丁比其他成分的抗氧化活性强。这表明具有邻二酚羟基结构的多元酚类化台物，有很强的抗氧化能力；邻二酚羟基是其抗氧化、清除氧自由基的主要活性部位。酚类化合物与氧自由基反应生成半醌式结构，由于邻二酚羟基的存在，其半醌式结构相对稳定，故表现出更强的抗氧化活性。
冬葵果为锦葵科植物冬葵的干燥成熟果实，别名：冬苋菜、滑花菜、葵子、葵菜子。冬葵果多糖由冬葵果提取纯化得到，对羟自由基、超氧阴离子自由基均有清除作用。冬葵果还含有氨基酸、蛋白质、多肽、鞣质、酚类、三萜、黄酮类、甾体，粘液质等化学成分，具有抗氧化，抑菌以及免疫等作用。
冬青叶提取物：冬青科系常绿乔木，为亚热带树种，主要分布在我国长江中下游流域及西南部分省区，资源十分丰富，是一类值得大力开发利用的野生天然药物资源。冬青叶提取物具有显著的抗菌、抗氧化、降压、消脂减肥等作用，活性成分主要为黄酮类、多酚类及皂甙、豆香素类等化学成分。其中黄酮和多酚具有较强的清除DPPH自由基和羟自由基的作用，将其添加至化妆品中具有美白肌肤，防衰老功效。
笃斯越桔又称笃斯、黑豆树(大兴安岭)、甸果、地果(吉林、临江)、龙果，为杜鹃花科越桔属落叶灌木。笃斯越桔在我国主要分布在内蒙古、黑龙江、吉林、辽宁等地区。笃斯越桔提取物具有很强清除自由基和抗氧化功能，具有抗衰老、协调平衡和增强记忆力作用；具有稳定胶原蛋白和促进胶原蛋白合成作用；具有减少毛细血管渗透性和抑制血小板凝集；具有预防前列腺素、白细胞三烯类和组织胺的合成和释放；笃斯越桔叶中的黄酮类化合物，具有解毒，利尿、消炎、降低血糖等功效。
青果，别名橄榄，是我国南方的名优水果，具有生津止渴、开脾胃、助消化、解治喉疾等药用和保健功效。青果中含有的多种化学成分具有较高药理活性，特别是其中可以提取分离较高活性的超氧化物岐化酶，是机体内O2-的天然清除剂，能起到保护细胞，抗衰老的作用，同样具有羟基自由基清除作用和超氧自由基的抑制作用的过氧化物酶和过氧化氢酶，这3种抗氧化酶在清除机体内多余超氧阴离子所造成的伤害时有相互协调作用。
败酱草，又称泽败、苦菜等，属败酱科多年生草本植物。它是我国常用中药，具有清热解毒之功效。研究表明，败酱草提取物含有较高的黄酮、皂苷等活性物质，对羟自由基有较强的清除作用，对超氧阴离子自由基也有一定的清除作用，可作为天然的抗衰老化妆品。
桑葚是桑科桑属多年生木本植物桑树的果实。桑葚提取物也称桑葚红色素，它含有丰富的活性蛋白、维生素、氨基酸、苹果酸等成分，主要成分为花色苷。营养成分是葡萄的4倍，苹果的5～6倍，具有多种功效，被医学界誉为“二十一世纪的最佳保健果品”。桑葚有改善皮肤的血液供应，营养肌肤，使皮肤白嫩及乌发等作用，并能延缓衰老。桑葚多糖能够清除自由基，阻断自由基反应链，具有一定的抗氧化及防衰老作用。
火棘果提取物：火棘为蔷薇科火棘属植物，在我国分布甚广，目前共分离得到约30种黄酮类化合物，其苷元主要为山奈酚、槲皮素、柚皮素、芹菜素等，常见的糖为鼠李糖、葡萄糖、阿拉伯糖、半乳糖，已被证实具有清除氧自由基，降血脂，增强免疫力，增强体力和促进消化功能等作用。黄酮类化合物具有抑制酪氨酸酶作用，表现出较强的美白活性，因此作为一种新的天然美白剂，火棘果有巨大开发潜力。
实施例1
一种精华液，含有以下质量百分比的各组分：护肤组合物1％、甘油5％、丁二醇3％、羟乙基纤维素钠0.2％、低聚果糖0.25％、透明质酸钠0.03％、EDTA二钠0.03％、甲基丙二醇2％、甘草酸二钾0.1％、烟酰胺3％、甘油聚甲基丙烯酸酯0.3％、甲氧基肉桂酸乙基己酯0.3％、PEG-100硬脂酸酯0.3％、聚山梨醇酯-800.85％、山梨坦硬脂酸酯0.2％、角鲨烷5％、辛基十二醇肉豆蔻酸酯2.5％、辛酸/癸酸甘油三酯2.5％、异十六烷2.5％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.25％、鲸蜡硬脂醇1％、牛油果树果脂0.5％、苯基三甲基硅氧烷1.5％、蜂蜡0.5％、生育酚乙酸酯0.5％、防腐剂0.4％、精氨酸0.2％、蜂胶提取物0.5％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物按质量之比为7：3：4:5组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散4分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质3分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散1分钟，搅拌均匀；降温至室温，出料。
实施例2
一种精华液，含有以下质量百分比的各组分：护肤组合物0.01％、甘油8％、丁二醇5％、羟乙基纤维素钠0.1％、低聚果糖0.5％、透明质酸钠0.05％、EDTA二钠0.01％、甲基丙二醇1％、甘草酸二钾0.15％、烟酰胺5％、甘油聚甲基丙烯酸酯0.1％、甲氧基肉桂酸乙基己酯0.5％、PEG-100硬脂酸酯0.5％、聚山梨醇酯-801％、山梨坦硬脂酸酯0.1％、角鲨烷10％、辛基十二醇肉豆蔻酸酯1％、辛酸/癸酸甘油三酯5％、异十六烷1％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.5％、鲸蜡硬脂醇1.5％、牛油果树果脂0.1％、苯基三甲基硅氧烷2.5％、蜂蜡0.1％、生育酚乙酸酯1％、防腐剂0.3％、精氨酸0.3％、蜂胶提取物1％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物按质量之比为10：1：1:10组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散5分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质3分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散2分钟，搅拌均匀；降温至室温，出料。
实施例3
一种精华液，含有以下质量百分比的各组分：护肤组合物10％、甘油1％、丁二醇1％、羟乙基纤维素钠0.3％、低聚果糖0.1％、透明质酸钠0.01％、EDTA二钠0.05％、甲基丙二醇3％、甘草酸二钾0.05％、烟酰胺1％、甘油聚甲基丙烯酸酯0.5％、甲氧基肉桂酸乙基己酯0.1％、PEG-100硬脂酸酯0.1％、聚山梨醇酯-800.5％、山梨坦硬脂酸酯0.3％、角鲨烷1％、辛基十二醇肉豆蔻酸酯5％、辛酸/癸酸甘油三酯1％、异十六烷5％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.1％、鲸蜡硬脂醇0.5％、牛油果树果脂1％、苯基三甲基硅氧烷0.5％、蜂蜡1％、生育酚乙酸酯0.1％、防腐剂0.6％、精氨酸0.1％、蜂胶提取物0.1％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物按质量之比为1：10：10:1组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散3分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质3分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散1分钟，搅拌均匀；降温至室温，出料。
实施例4
一种精华液，含有以下质量百分比的各组分：护肤组合物3％、甘油3％、丁二醇4％、羟乙基纤维素钠0.25％、低聚果糖0.35％、透明质酸钠0.02％、EDTA二钠0.02％、甲基丙二醇2.5％、甘草酸二钾0.08％、烟酰胺4％、甘油聚甲基丙烯酸酯0.2％、甲氧基肉桂酸乙基己酯0.4％、PEG-100硬脂酸酯0.3％、聚山梨醇酯-800.8％、山梨坦硬脂酸酯0.25％、角鲨烷8％、辛基十二醇肉豆蔻酸酯4％、辛酸/癸酸甘油三酯3％、异十六烷2％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.3％、鲸蜡硬脂醇0.9％、牛油果树果脂0.8％、苯基三甲基硅氧烷1.5％、蜂蜡0.7％、生育酚乙酸酯0.6％、防腐剂0.5％、精氨酸0.25％、蜂胶提取物0.7％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物、青果提取物、败酱草提取物、桑葚提取物、火棘果提取物按质量之比为7：3：4:5:4:3:7:5组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散5分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质4分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散2分钟，搅拌均匀；降温至室温，出料。
实施例5
一种精华液，含有以下质量百分比的各组分：护肤组合物0.5％、甘油6％、丁二醇3％、羟乙基纤维素钠0.15％、低聚果糖0.45％、透明质酸钠0.03％、EDTA二钠0.04％、甲基丙二醇1.5％、甘草酸二钾0.09％、烟酰胺3.5％、甘油聚甲基丙烯酸酯0.4％、甲氧基肉桂酸乙基己酯0.2％、PEG-100硬脂酸酯0.3％、聚山梨醇酯-800.8％、山梨坦硬脂酸酯0.3％、角鲨烷7％、辛基十二醇肉豆蔻酸酯4％、辛酸/癸酸甘油三酯2％、异十六烷3％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.3％、鲸蜡硬脂醇0.9％、牛油果树果脂0.6％、苯基三甲基硅氧烷2％、蜂蜡0.7％、生育酚乙酸酯0.4％、防腐剂0.4％、精氨酸0.2％、蜂胶提取物0.8％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物、青果提取物、败酱草提取物、桑葚提取物、火棘果提取物按质量之比为10：10：1:1:10:1:10:1组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散5分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质5分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散1分钟，搅拌均匀；降温至室温，出料。
实施例6
一种精华液，含有以下质量百分比的各组分：护肤组合物7％、甘油6％、丁二醇2％、羟乙基纤维素钠0.16％、低聚果糖0.37％、透明质酸钠0.03％、EDTA二钠0.02％、甲基丙二醇1.7％、甘草酸二钾0.08％、烟酰胺2.6％、甘油聚甲基丙烯酸酯0.4％、甲氧基肉桂酸乙基己酯0.36％、PEG-100硬脂酸酯0.4％、聚山梨醇酯-800.6％、山梨坦硬脂酸酯0.2％、角鲨烷6％、辛基十二醇肉豆蔻酸酯4％、辛酸/癸酸甘油三酯3％、异十六烷2％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.4％、鲸蜡硬脂醇0.7％、牛油果树果脂0.8％、苯基三甲基硅氧烷2％、蜂蜡0.6％、生育酚乙酸酯0.4％、防腐剂0.5％、精氨酸0.1％、蜂胶提取物0.7％、水余量。
所述护肤组合物由单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物、青果提取物、败酱草提取物、桑葚提取物、火棘果提取物按质量之比为1：1：10:10:1:10:1:10组成。
所述防腐剂为聚季铵盐-15和1,2-己二醇按质量之比为1:3组成。
所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散4分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质4分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、上述护肤组合物，2000rpm均质分散2分钟，搅拌均匀；降温至室温，出料。
对比例1
与实施例1的区别在于，未添加单子山楂叶提取物。
对比例2
与实施例1的区别在于，未添加冬葵果提取物。
对比例3
与实施例1的区别在于，未添加冬青叶提取物。
对比例4
与实施例1的区别在于，未添加笃斯越桔果提取物。
对比例5
与实施例4的区别在于，未添加青果提取物。
对比例6
与实施例4的区别在于，未添加败酱草提取物。
对比例7
与实施例4的区别在于，未添加桑葚提取物。
对比例8
与实施例4的区别在于，未添加火棘果提取物。
对实施例1-6和对比例1-8制备的乳液进行试用检测效果。
测试对象：各实验组均为20名女性(25-50岁)；
测试区域：前臂内侧和鱼尾纹区域；
使用：每天两次，持续使用4周；
测试项目：皮肤湿度、肤色暗沉、皮肤嫩滑度、皮肤皱纹。
试用结果见表1。
从表1中可看出，实施例1-6所制得的精华液具有良好的保湿、美白、抗皱和抗衰老效果。
对比例1-4与实施例1-3对比可见，单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物是精华液发挥保湿、美白、抗皱和抗衰老效果的关键成分，且单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物合用时精华液的效果才明显，体现了协同增效作用。
实施例4-6与实施例1-3对比可见，青果提取物、败酱草提取物、桑葚提取物、火棘果提取物的加入大幅度提升了所述精华液的保湿、美白、抗皱和抗衰老的效果；且对比例5-8与实施例4-6对比可见，青果提取物、败酱草提取物、桑葚提取物、火棘果提取物合用时才能体现出提升效果，具有协同增效的作用。
以上所述，仅是本发明的较佳实施例而已，并非对本发明做任何形式上的限制，故凡未脱离本发明技术方案的内容，依据本发明的技术实质对以上实施例所做的任何简单修改、等同变化与修饰，均仍属于本发明技术方案的范围内。
Claims (8)
1.一种天然抗衰老护肤组合物，其特征在于，所述的护肤组合物含有如下所述的原料：单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物；所述的单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)。
2.根据权利要求1所述的护肤组合物，其特征在于，所述的护肤组合物还含有如下所述的原料：青果提取物、败酱草提取物、桑葚提取物、火棘果提取物；所述的青果提取物、败酱草提取物、桑葚提取物、火棘果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)。
3.根据权利要求1或2所述的护肤组合物，其特征在于，所述的单子山楂叶提取物、冬葵果提取物、冬青叶提取物、笃斯越桔果提取物、青果提取物、败酱草提取物、桑葚提取物、火棘果提取物的质量之比为(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)：(1-10)。
4.根据权利要求1-3任一项所述的护肤组合物在制备化妆品中的应用，其中，所述护肤组合物的用量为最终产品用量的0.01-10％。
5.一种精华液，其特征在于，含有以下质量百分比的各组分：如权利要求1-3任一项所述的护肤组合物0.01-10％、甘油1-10％、丁二醇1-5％、羟乙基纤维素钠0.1-0.3％、低聚果糖0.1-0.5％、透明质酸钠0.01-0.05％、EDTA二钠0.01-0.05％、甲基丙二醇1-3％、甘草酸二钾0.05-0.15％、烟酰胺1-5％、甘油聚甲基丙烯酸酯0.1-0.5％、甲氧基肉桂酸乙基己酯0.1-0.5％、PEG-100硬脂酸酯0.1-0.5％、聚山梨醇酯-800.5-1％、山梨坦硬脂酸酯0.1-0.3％、角鲨烷1-10％、辛基十二醇肉豆蔻酸酯1-5％、辛酸/癸酸甘油三酯1-5％、异十六烷1-5％、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物0.1-0.5％、鲸蜡硬脂醇0.5-1.5％、牛油果树果脂0.1-1％、苯基三甲基硅氧烷0.5-2.5％、蜂蜡0.1-1％、生育酚乙酸酯0.1-1％、防腐剂0.3-0.6％、精氨酸0.1-0.3％、蜂胶提取物0.1-1％、水余量。
6.根据权利要求5所述的精华液，其特征在于，所述防腐剂为聚季铵盐-15和1,2-己二醇的混合。
7.根据权利要求6所述的精华液，其特征在于，所述聚季铵盐-15和1,2-己二醇的质量之比为1:3。
8.根据权利要求5所述的精华液，其特征在于，所述精华液的制备方法包括如下步骤：1、将甘油聚甲基丙烯酸酯、甲氧基肉桂酸乙基己酯、PEG-100硬脂酸酯、聚山梨醇酯-80、山梨坦硬脂酸酯、角鲨烷、辛基十二醇肉豆蔻酸酯、辛酸/癸酸甘油三酯、异十六烷、丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、鲸蜡硬脂醇、牛油果树果脂、苯基三甲基硅氧烷、蜂蜡、生育酚乙酸酯投入油相锅，加热到80℃，制得油相，作为B备用；2、将甘油、丁二醇、羟乙基纤维素钠、低聚果糖、透明质酸钠、EDTA二钠、甲基丙二醇、甘草酸二钾、烟酰胺、水投入乳化锅，加热到80℃，2000rpm均质分散3-5分钟，制得透明水相，保温20分钟,作为A相；3、将B相抽入乳化锅，3000rpm均质3-5分钟，搅拌下保温20分钟；4、降温至45℃，投入防腐剂、精氨酸、蜂胶提取物、如权利要求1-3任一项所述的护肤组合物，2000rpm均质分散1-2分钟，搅拌均匀；降温至室温，出料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810282709.3A CN108186483A (zh) | 2018-03-31 | 2018-03-31 | 一种天然抗衰老护肤组合物及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810282709.3A CN108186483A (zh) | 2018-03-31 | 2018-03-31 | 一种天然抗衰老护肤组合物及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108186483A true CN108186483A (zh) | 2018-06-22 |
Family
ID=62596630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810282709.3A Withdrawn CN108186483A (zh) | 2018-03-31 | 2018-03-31 | 一种天然抗衰老护肤组合物及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108186483A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108578296A (zh) * | 2018-06-27 | 2018-09-28 | 广州市科能化妆品科研有限公司 | 一种抗衰老中药提取组合物及其制备和在化妆品中的应用 |
| CN109568506A (zh) * | 2018-12-28 | 2019-04-05 | 威海百合生物技术股份有限公司 | 一种美颜抗衰老组合物及其制备方法 |
| CN115869230A (zh) * | 2022-12-21 | 2023-03-31 | 广东药科大学 | 一种抗皱化妆品及其制备方法 |
-
2018
- 2018-03-31 CN CN201810282709.3A patent/CN108186483A/zh not_active Withdrawn
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108578296A (zh) * | 2018-06-27 | 2018-09-28 | 广州市科能化妆品科研有限公司 | 一种抗衰老中药提取组合物及其制备和在化妆品中的应用 |
| CN109568506A (zh) * | 2018-12-28 | 2019-04-05 | 威海百合生物技术股份有限公司 | 一种美颜抗衰老组合物及其制备方法 |
| CN115869230A (zh) * | 2022-12-21 | 2023-03-31 | 广东药科大学 | 一种抗皱化妆品及其制备方法 |
| CN115869230B (zh) * | 2022-12-21 | 2024-11-12 | 广东药科大学 | 一种抗皱化妆品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101310970B1 (ko) | 탈모방지용 한방추출물 및 이를 포함하는 헤어용품 조성물 | |
| KR101315265B1 (ko) | 피부노화개선용 화장료조성물 | |
| KR102030021B1 (ko) | 마사지용 화장료 조성물 | |
| KR20090055309A (ko) | 피부미백 및 주름개선용 피부외용 화장료 조성물 | |
| KR101387308B1 (ko) | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 | |
| US8445039B2 (en) | Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily | |
| CN108653136A (zh) | 一种用于化妆品霜乳及面膜的中药组合物及其混合提取液 | |
| CN105687035B (zh) | 一种具有抗氧化、延缓肌肤衰老作用的复合银杏精油 | |
| KR20120087451A (ko) | 천연 식물 추출물을 함유하는 기능성 화장료 조성물 | |
| CN108186483A (zh) | 一种天然抗衰老护肤组合物及其应用 | |
| KR101498609B1 (ko) | 한방약초농축액을 이용한 천연 한방 바디로션 제조방법 및 이를 이용하여 제조한 천연 한방 바디로션 조성물 | |
| CN104971015A (zh) | 一种专供油性皮肤使用的面膜产品及其制备方法 | |
| KR102137951B1 (ko) | 버섯복합추출물을 포함하는 피부 진정 효과를 가지는 화장료 조성물 및 그 제조방법 | |
| KR101930264B1 (ko) | 현호색, 캣츠클로, 센티드제라늄, 아그리모니, 인동덩굴, 개박하 및 솔잣나무 복합추출물을 유효성분으로 함유하는 피지생성 억제 및 여드름 개선용 화장료 조성물 | |
| KR102447999B1 (ko) | 티트리잎, 페퍼민트잎, 약모밀, 녹차, 노니 및 파슬리의 혼합 추출물을 유효성분으로 함유하는 피부 탄력 개선용 화장료 조성물 | |
| KR101829891B1 (ko) | 은목서 추출물 및 사위질빵 추출물을 유효성분으로 함유하는 화장료 조성물 | |
| KR20140096738A (ko) | 녹나무 추출물을 함유한 비누 및 피부미백제 | |
| CN108309852A (zh) | 一种香水莲花保湿组合物及其应用 | |
| KR101954275B1 (ko) | 골드키위 껍질 및 용과 껍질의 복합 추출물을 유효 성분으로 함유하는 화장료 조성물 및 이의 제조 방법 | |
| KR102703018B1 (ko) | 천연식물 유래의 복합 추출물을 유효성분으로 포함하는 질 분비물 냄새 제거용 소취제 조성물 | |
| KR102429389B1 (ko) | 천연식물 유래의 복합 추출물을 유효성분으로 포함하는 피 냄새 제거용 소취제 조성물 | |
| CN105441230A (zh) | 一种茶油冷制皂 | |
| KR101537293B1 (ko) | 포제 처리된 감국 또는 진피 추출물을 함유하는 항산화용 화장료 조성물 | |
| KR101620950B1 (ko) | 피부 세포 재생 효과, 항산화 효과, 항균 효과 및 항염증 효과를 갖는 화장용 조성물의 제조방법 및 이에 의해 제조된 피부 세포 재생 효과, 항산화 효과, 항균 효과 및 항염증 효과를 갖는 화장용 조성물 | |
| KR20150105721A (ko) | 구기자나무의 복합추출물을 유효성분으로 함유하는 피부 노화 억제 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180622 |